These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates. Choi MJ, Ko KS. J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018 [No Abstract] [Full Text] [Related]
3. [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009]. Hamouche E, Sarkis DK. Pathol Biol (Paris); 2012 Jun; 60(3):e15-20. PubMed ID: 21719212 [Abstract] [Full Text] [Related]
4. Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance. Meletis G, Oustas E, Botziori C, Kakasi E, Koteli A. New Microbiol; 2015 Jul; 38(3):417-21. PubMed ID: 26147150 [Abstract] [Full Text] [Related]
5. Mutant prevention concentrations of colistin used in combination with other antimicrobial agents against Acinetobacter baumannii, Klebsiella pneumoniae and Pseudomonas aeruginosa clinical isolates. Choi MJ, Park YK, Peck KR, Ko KS. Int J Antimicrob Agents; 2014 Nov; 44(5):475-6. PubMed ID: 25443890 [No Abstract] [Full Text] [Related]
9. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009. Mohammadtaheri Z, Pourpaki M, Mohammadi F, Namdar R, Masjedi MR. Chemotherapy; 2010 Nov; 56(6):478-84. PubMed ID: 21099220 [Abstract] [Full Text] [Related]
10. Prevalence of multidrug-resistant bacteria at a tertiary-care teaching hospital in Mexico: special focus on Acinetobacter baumannii. Garza-González E, Llaca-Díaz JM, Bosques-Padilla FJ, González GM. Chemotherapy; 2010 Nov; 56(4):275-9. PubMed ID: 20693798 [Abstract] [Full Text] [Related]
14. Prevalence of multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in an Italian hospital. De Francesco MA, Ravizzola G, Peroni L, Bonfanti C, Manca N. J Infect Public Health; 2013 Jun; 6(3):179-85. PubMed ID: 23668462 [Abstract] [Full Text] [Related]
15. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011. Zhang X, Gu B, Mei Y, Wen Y, Xia W. J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483 [Abstract] [Full Text] [Related]
18. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study]. Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, Eraç B, Gültekin M, Oğünç D, Söyletir G, Unal N, Uysal S. Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074 [Abstract] [Full Text] [Related]
19. Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient. Creighton J, Heffernan H, Howard J. J Antimicrob Chemother; 2017 Jan; 72(1):317-319. PubMed ID: 27621176 [No Abstract] [Full Text] [Related]